Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is E  [Clear All Filters]
2004
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
Cropper EC, Evans CG, Jing J, Klein A, Proekt A, Romero A, Rosen SC.  2004.  Regulation of afferent transmission in the feeding circuitry of Aplysia.. Acta Biol Hung. 55(1-4):211-20.
2003
Estévez R, Schroeder BC, Accardi A, Jentsch TJ, Pusch M.  2003.  Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1.. Neuron. 38(1):47-59.
Evans CG, Jing J, Proekt A, Rosen SC, Cropper EC.  2003.  Frequency-dependent regulation of afferent transmission in the feeding circuitry of Aplysia.. J Neurophysiol. 90(6):3967-77.
Liantonio A, De Luca A, Pierno S, Didonna MPaola, Loiodice F, Fracchiolla G, Tortorella P, Antonio L, Bonerba E, Traverso S et al..  2003.  Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.. Br J Pharmacol. 139(7):1255-64.
2002
Goldstein PA, Elsen FP, Ying S-W, Ferguson C, Homanics GE, Harrison NL.  2002.  Prolongation of hippocampal miniature inhibitory postsynaptic currents in mice lacking the GABA(A) receptor alpha1 subunit.. J Neurophysiol. 88(6):3208-17.
2000
Eldin S, Forget AL, Lindenmuth DM, Logan KM, Knight KL.  2000.  Mutations in the N-terminal region of RecA that disrupt the stability of free protein oligomers but not RecA-DNA complexes.. J Mol Biol. 299(1):91-101.
1996
Savarese JJ, Erickson H, Scully SP.  1996.  Articular chondrocyte tenascin-C production and assembly into de novo extracellular matrix.. J Orthop Res. 14(2):273-81.
1995
Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ.  1995.  The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1131-8.
Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ.  1995.  The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1139-45.
1994
Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ.  1994.  The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 80(6):1296-302.
Abramson DH, Gamell LS, Ellsworth RM, Kruger EF, Servodidio CA, Turner L, Sussman D.  1994.  Unilateral retinoblastoma: new intraocular tumours after treatment.. Br J Ophthalmol. 78(9):698-701.
1993
Lien CA, Gadalla F, Kudlak TT, Embree PB, Sharp GJ, Savarese JJ.  1993.  The effect of ondansetron on atracurium-induced neuromuscular blockade.. J Clin Anesth. 5(5):399-403.
1991
Abramson DH, Gerardi CM, Ellsworth RM, McCormick B, Sussman D, Turner L.  1991.  Radiation regression patterns in treated retinoblastoma: 7 to 21 years later.. J Pediatr Ophthalmol Strabismus. 28(2):108-12.
1990
el-Gewaily M, al-Sayyed J, Gadalla F.  1990.  Factors influencing utilization of the curative health services among children aged 6-60 months in Bahrain (Part II).. J Egypt Public Health Assoc. 65(5-6):617-27.
Dresner DL, Basta SJ, Ali HH, Schwartz AF, Embree PB, Wargin WA, Lai AA, Brady KA, Savarese JJ.  1990.  Pharmacokinetics and pharmacodynamics of doxacurium in young and elderly patients during isoflurane anesthesia.. Anesth Analg. 71(5):498-502.
Hemmings HC, Nairn AC, Elliott JI, Greengard P.  1990.  Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.. J Biol Chem. 265(33):20369-76.
1989
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.  1989.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.
Elgewaily M, al-Sayyed J, Gadalla F.  1989.  Factors influencing utilization of the preventive health services among children aged 6-60 months in Bahrain. Part I.. J Egypt Public Health Assoc. 64(1-2):145-54.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of mivacurium in children.. Anesthesiology. 70(2):237-42.
1988
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.  1988.  Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.  1988.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.